Despite Pfizer's (NYSE: PFE) recent struggles with falling earnings and a bid by an activist investor to unseat its ...

Pharmaceutical giant Pfizer (PFE) now sports a dividend yield of 6.5%. Is this stock a smart addition to the income section ...

Goldman Sachs hosted a meeting with Pfizer Inc’s (NYSE:PFE) newly appointed Chief Scientific Officer Chris Boshoff (effective ...

Company veteran Chris Boshoff, who has led Pfizer’s cancer research and marketing for more than a year, will become chief ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Pharma vs pushes back as Senators look into telehealth moves, startups using AI for small molecule drugs, and more.

No financial details of the collaborations were released. However, Pfizer and Flagship committed $50 million each for the ...

Pfizer (NYSE:PFE) discovers, develops, manufactures, markets, distributes and sells biopharmaceutical products in the United ...

The pharma leader is betting that streamlined services may be a shot in the arm for Americans seeking care with its ...

Is the healthcare stock in big trouble and headed for a greater decline, or are investors perhaps a bit too bearish on the ...

Lilly and Pfizer stocks have sold off sharply in recent weeks. Both drugmakers have had some bad news that caused their stock ...

It’ll be a busy December for dividend growth investors, with 25 companies announcing their annual increases. Check out the ...